Clinical Trial Update: Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tamoxifen therapy for pulmonary arterial hypertension has completed, with results posted in December 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Pulmonary Arterial Hypertension
• Hypertension
• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Hypertension, Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-12-05